Annual report pursuant to Section 13 and 15(d)

Consolidated Statements of Operations

v3.20.2
Consolidated Statements of Operations - USD ($)
12 Months Ended
Sep. 30, 2020
Sep. 30, 2019
Consolidated Statements of Operations    
Revenues $ 0 $ 0
Operating expenses:    
General and administrative expenses 3,759,554 3,974,919
Research and development expenses 1,611,094 2,396,838
Total operating expenses 5,370,648 6,371,757
Operating loss (5,370,648) (6,371,757)
Other income    
Decrease to fair value of derivative 679,271 1,824,175
Total other income 679,271 1,824,175
Net loss $ (4,691,377) $ (4,547,582)
Earnings per share - basic and diluted    
Net loss per common share - basic and diluted $ (0.02) $ (0.03)
Weighted average shares - basic and diluted 188,051,683 166,339,862